Australia Archives | Page 4 of 9 | Be Korea-savvy
Don’t Miss Australia’s Largest Aboriginal and Torres Strait Islander Visual Art Event

Don’t Miss Australia’s Largest Aboriginal and Torres Strait Islander Visual Art Event

DARWIN, Australia, Aug. 3 (Korea Bizwire) — The Darwin Aboriginal Art Fair (DAAF) will open Friday 6 August via its cutting-edge digital platform, connecting audiences around the world with Australia’s Aboriginal and Torres Strait Islander creatives. Presented by Darwin Aboriginal Art Fair Foundation (DAAFF), now in its 15th year, the DAAF program will run from 6-11 [...]

George Clinical and Omico Align to Evolve Oncology Study Enrollment Through Genomic Profiling in Australia

George Clinical and Omico Align to Evolve Oncology Study Enrollment Through Genomic Profiling in Australia

SYDNEY, June 15 (Korea Bizwire) — George Clinical, a global scientifically-backed clinical research organization, and Omico, an Australian-based not-for-profit national precision oncology platform, have aligned to revolutionize oncology clinical trial access for patients and improve the efficiency of study enrollment.  The two organizations began collaborating in late 2020 and announced the joint effort during the [...]

Colliers International Appoints New Chief Executive Officer for Australian Business

Colliers International Appoints New Chief Executive Officer for Australian Business

TORONTO, Jan. 21 (Korea Bizwire) — Leading diversified professional services and investment management firm, Colliers International (NASDAQ and TSX: CIGI) today announced that Malcom Tyson has been appointed as Chief Executive Officer | Australia. Tyson has been a senior member of Colliers’ Australian and New Zealand Executive Leadership team since 2005 and held a variety [...]

Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine

Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine

GAITHERSBURG, Md., Jan. 7 (Korea Bizwire) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has executed an Advance Purchase Agreement with the Commonwealth of Australia for 51 million doses of NVX-CoV2373, Novavax’ COVID-19 vaccine candidate. This follows an agreement in principle that was [...]

Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine

Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine

GAITHERSBURG, Md., Nov. 4 (Korea Bizwire) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the signing of a non-binding Heads of Terms document with the Australian Government to supply 40 million doses of the Company’s COVID-19 vaccine candidate, NVX-CoV2373, for the Australian community. “This [...]